PROMACTA® (eltrombopag) | Patient Website
PROMACTA is a prescription medicine used to treat adults and children 1 year and older with low blood platelet counts due to persistent or chronic immune thrombocytopenia (ITP) when other medicines to …
Taking PROMACTA | PROMACTA® (eltrombopag)
Find dosing information and instructions for taking PROMACTA for persistent or chronic ITP. See full Prescribing & Safety Info, including Boxed WARNING.
Understanding PROMACTA | PROMACTA® (eltrombopag)
PROMACTA is a platelet booster that functions differently than steroids or intravenous immunoglobulin (IVIg). It works with your body to create more platelets so it can make up for the ones your body is …
Persistent or Chronic ITP | PROMACTA® (eltrombopag)
PROMACTA is a prescription medicine used to treat adults and children 1 year and older with low blood platelet counts due to persistent or chronic immune thrombocytopenia (ITP)
Understanding Side Effects | PROMACTA® (eltrombopag)
PROMACTA is a prescription medicine used to treat adults and children 1 year and older with low blood platelet counts due to persistent or chronic immune thrombocytopenia (ITP)
Learn How You Can Save on PROMACTA
PROMACTA is a prescription medicine used to treat adults and children 1 year and older with low blood platelet counts due to persistent or chronic immune thrombocytopenia (ITP)
Take Charge of Your SAA - PROMACTA
PROMACTA is a prescription medicine used to treat people with severe aplastic anemia (SAA) in combination with standard immunosuppressive therapy as the first treatment for adults and children …
How PROMACTA May Work for Your Child
PROMACTA is the only once-daily oral platelet booster that is available as a tablet and an oral suspension. It is also the only oral platelet booster approved to treat persistent or chronic immune …
My Journey Ahead with PROMACTA
PROMACTA is a prescription medicine used to treat adults and children 1 year and older with low blood platelet counts due to persistent or chronic immune thrombocytopenia (ITP)
us.promacta.com
/severe-aplastic-anemia/about-promacta/monitoring-treatment